Skip to content
Home/Companies/MedTech/preCARDIA
PR

preCARDIA

MedTech·US·Exited 2021·Held 5yr

preCARDIA is a healthcare / medtech company, headquartered in United States.

Entry
2016
Hold
5yr
Exit
2021
Est. EV
–

Who owns preCARDIA?

preCARDIA was owned by Sofinnova Partners through Sofinnova MD Start (2010 vintage) from 2016 to 2021, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova MD Start · 2010 · VC

Key facts

HQUnited States
SectorHealthcare / Medtech
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021

More from Sofinnova MD Start

Other portfolio companies in the same fund.

Gradient Denervation Technologies
Active
MedTechUS· 2023
Julier Medical
Active
MedTechFrance· 2023
BrightHeart
Active
MedTechFrance· 2022
HEPTA Medical
Active
MedTechFrance· 2022
Tulyp Medical
Active
MedTechFrance· 2022
Endoron Medical
Active
MedTechFrance· 2021

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aflo
Active
Clarendon Fund ManagersUnited Kingdom
Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Data refreshed weekly · Sourced from public filings